Table 2 Treatment delivery
Characteristic | Arm without CTV n (%) | Arm with CTV n (%) |
|---|---|---|
No. of eligible patients | 54(100) | 35(100) |
Treatment schedule | ||
Induction chemo + RT | 6(11.1) | 8(22.9) |
Concurrent chemo alone | 2(3.7) | 2(5.7) |
Induction + concurrent t adjuvant chemo | 11(20.4) | 13(37.1) |
Induction + concurrent chemo | 26(48.1) | 10(28.6) |
Concurrent + adjuvant chemo | 8(14.8) | 2(5.7) |
Induction + RT adjuvant chemo | 1(1.9) | 0(0) |
Induction chemo (cycles) | ||
0 | 10(18.5) | 4(11.4) |
1 | 15(27.8) | 9(25.7) |
2 | 13(24.1) | 7(20.0) |
≥3 | 16(29.6) | 15(42.9) |
Concurrent chemo (cycles) | ||
0 | 7(13.0) | 8(22.8) |
1 | 9(16.7) | 5(14.3) |
2 | 34(63.0) | 14(40.0) |
3 | 4(7.4) | 8(22.8) |
Adjuvant chemo (cycles) | ||
0 | 34(63.0) | 20(57.1) |
1 | 8(14.8) | 5(14.3) |
2 | 11(20.4) | 9(25.7) |
3 | 1(1.9) | 1(2.9) |
PCI | ||
Without PCI | 25(46.3) | 18(51.4) |
With PCI | 29(53.7) | 17(48.6) |